A pandemic is not inevitable, scientists say. But the outbreak has passed worrisome milestones in recent weeks, including ...

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and ... Moderna plans to advance ...

Traws Pharma has completed the Phase I clinical trials of tivoxavir marboxil, a single-dose drug for treating or preventing ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

Earlier this month, Moderna announced business updates and progress across its pipeline. Moderna says it enters 2025 with a ...

The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...

Moderna gets a $590 million federal boost to continue work on development of a vaccine to protect against bird flu.

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect ... Moderna plans to advance research on the mRNA vaccine into a phase 3 trial after receiving positive results ...